Peijia Medical Limited - Laporan Laba Rugi (TTM)

Peijia Medical Limited
US ˙ OTCPK ˙ KYG6981F1090

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Peijia Medical Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 33 39 57 76 106 137 170 204 227 251 304 357 399 441 479 517 566 615 642 668
Change (%) 16.51 48.44 32.63 39.70 28.42 24.58 19.73 11.59 10.38 21.14 17.45 11.80 10.55 8.65 7.96 9.47 8.65 4.24 4.07
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 12 13 18 22 32 41 52 62 68 75 83 91 103 116 131 146 164 182 194 205
Change (%) 13.97 33.52 25.10 41.10 29.13 26.06 20.67 10.01 9.10 10.93 9.85 13.64 12.00 13.14 11.62 12.20 10.88 6.44 6.05
% of Revenue 35.52 34.75 31.25 29.48 29.78 29.94 30.30 30.54 30.10 29.75 27.25 25.48 25.90 26.24 27.33 28.25 28.95 29.55 30.17 30.75
Gross Operating Profit 21 25 39 54 75 96 119 141 159 176 221 266 296 325 348 371 402 434 448 462
Change (%) 17.91 56.39 36.06 39.11 28.12 23.94 19.32 12.28 10.94 25.47 20.30 11.17 10.05 7.05 6.59 8.40 7.75 3.32 3.21
% of Revenue 64.48 65.25 68.75 70.52 70.22 70.06 69.70 69.46 69.90 70.25 72.75 74.52 74.10 73.76 72.67 71.75 71.05 70.45 69.83 69.25
SG&A 180 139 141 143 176 208 246 285 325 365 406 447 457 467 456 446 463 479 476 473
Change (%) -22.77 1.54 1.51 22.43 18.32 18.66 15.73 14.00 12.28 11.26 10.12 2.16 2.12 -2.17 -2.22 3.71 3.58 -0.66 -0.67
% of Revenue 542.84 359.84 246.14 188.39 165.09 152.11 144.89 140.05 143.08 145.54 133.66 125.32 114.52 105.78 95.24 86.25 81.71 77.90 74.23 70.85
R&D 92 103 109 114 123 131 141 151 149 147 153 159 182 205 214 223 213 203 211 219
Change (%) 12.70 5.02 4.78 7.71 7.16 7.44 6.92 -1.27 -1.28 4.18 4.01 14.50 12.66 4.16 4.00 -4.31 -4.50 3.72 3.59
% of Revenue 276.46 267.40 189.19 149.47 115.25 96.17 82.94 74.07 65.54 58.61 50.40 44.63 45.71 46.58 44.66 43.02 37.60 33.05 32.89 32.74
OpEx 276 247 261 274 323 372 432 491 523 574 630 685 737 770 778 787 816 845 861 876
Change (%) -10.25 5.40 5.12 17.94 15.21 15.90 13.72 6.51 9.74 9.77 8.85 7.50 4.46 1.04 1.23 3.70 3.56 1.83 1.79
% of Revenue 830.75 639.97 454.39 360.14 304.03 272.75 253.75 241.01 230.05 228.71 207.23 192.06 184.68 174.49 162.26 152.14 144.12 137.37 134.19 131.26
Operating Income -242 -209 -203 -198 -217 -236 -262 -287 -296 -323 -326 -329 -328 -327 -298 -270 -250 -230 -219 -209
Change (%) -13.91 -2.57 -2.64 9.57 8.73 10.87 9.81 2.91 9.25 0.93 0.84 -0.23 -0.23 -8.75 -9.59 -7.38 -7.97 -4.63 -4.86
% of Revenue -730.75 -539.97 -354.39 -260.14 -204.03 -172.75 -153.75 -141.01 -130.05 -128.71 -107.23 -92.06 -82.15 -74.14 -62.26 -52.14 -44.12 -37.37 -34.19 -31.26
Interest Expense -0 -0 -0 -0 -0 -0 -1 -1 -2 -2 -2 -1 -1 -0 -0 -0 -2 -5 -8 -10
Change (%) -62.78 -6.59 -7.06 67.72 40.38 290.05 74.36 41.54 29.35 -21.37 -27.18 -43.29 -76.33 0.28 0.28 1,272.91 92.72 60.00 37.50
% of Revenue -0.74 -0.24 -0.15 -0.10 -0.12 -0.14 -0.43 -0.62 -0.79 -0.92 -0.60 -0.37 -0.19 -0.04 -0.04 -0.03 -0.43 -0.77 -1.18 -1.56
Net Income -2,128 -2,069 -1,262 -455 -515 -574 -533 -491 -449 -408 -468 -528 -460 -393 -322 -252 -239 -227 -226 -225
Change (%) -2.79 -39.00 -63.95 13.11 11.59 -7.24 -7.81 -8.47 -9.26 14.72 12.83 -12.82 -14.71 -17.93 -21.85 -5.00 -5.26 -0.31 -0.31
% of Revenue -6,414.03 -5,351.59 -2,198.99 -597.73 -483.98 -420.57 -313.14 -241.12 -197.77 -162.58 -153.96 -147.91 -115.33 -88.98 -67.21 -48.65 -42.22 -36.81 -35.21 -33.73

Source: Capital IQ

Other Listings
DE:4WO € 0.82
HK:9996 HK$ 7.42
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista